- Home
- EVRI vs TVTX Comparison
EVRI vs TVTX Comparison
Compare EVRI & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVRI
- TVTX
- Stock Information
- Founded
- EVRI 1998
- TVTX 2008
- Country
- EVRI United States
- TVTX United States
- Employees
- EVRI N/A
- TVTX N/A
- Industry
- EVRI Services-Misc. Amusement & Recreation
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- EVRI Consumer Discretionary
- TVTX Health Care
- Exchange
- EVRI Nasdaq
- TVTX Nasdaq
- Market Cap
- EVRI 1.2B
- TVTX 1.3B
- IPO Year
- EVRI 2005
- TVTX N/A
- Fundamental
- Price
- EVRI $13.77
- TVTX $14.92
- Analyst Decision
- EVRI Hold
- TVTX Strong Buy
- Analyst Count
- EVRI 4
- TVTX 13
- Target Price
- EVRI $12.83
- TVTX $33.75
- AVG Volume (30 Days)
- EVRI 1.9M
- TVTX 2.0M
- Earning Date
- EVRI 05-07-2025
- TVTX 05-05-2025
- Dividend Yield
- EVRI N/A
- TVTX N/A
- EPS Growth
- EVRI N/A
- TVTX N/A
- EPS
- EVRI 0.17
- TVTX N/A
- Revenue
- EVRI $757,903,000.00
- TVTX $233,175,000.00
- Revenue This Year
- EVRI $3.49
- TVTX $68.31
- Revenue Next Year
- EVRI $4.01
- TVTX $55.65
- P/E Ratio
- EVRI $81.00
- TVTX N/A
- Revenue Growth
- EVRI N/A
- TVTX 60.55
- 52 Week Low
- EVRI $6.37
- TVTX $5.12
- 52 Week High
- EVRI $13.83
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- EVRI 58.61
- TVTX 37.07
- Support Level
- EVRI $13.17
- TVTX $14.13
- Resistance Level
- EVRI $13.62
- TVTX $15.23
- Average True Range (ATR)
- EVRI 0.16
- TVTX 1.31
- MACD
- EVRI 0.03
- TVTX -0.10
- Stochastic Oscillator
- EVRI 95.24
- TVTX 31.70
About EVRI Everi Holdings Inc.
Everi Holdings Inc provides entertainment and technology solutions for the casino, interactive, and gaming industry. It operates in two segments namely Games and Financial Technology Solutions (FinTech). Enveri Games provides gaming operators with gaming technology products and services which include gaming machines, slot machines, leased gaming equipment, and other products and services. Enveri FinTech provides gaming operators with financial technology products and services which include services and equipment that facilitate casino patron's to access cash at gaming facilities through automated teller machines, point of sale debit card purchases and others.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.